206 related articles for article (PubMed ID: 15755690)
1. Platform influence on DNA microarray data in postmortem brain research.
Hollingshead D; Lewis DA; Mirnics K
Neurobiol Dis; 2005 Apr; 18(3):649-55. PubMed ID: 15755690
[TBL] [Abstract][Full Text] [Related]
2. Cross platform microarray analysis for robust identification of differentially expressed genes.
Bosotti R; Locatelli G; Healy S; Scacheri E; Sartori L; Mercurio C; Calogero R; Isacchi A
BMC Bioinformatics; 2007 Mar; 8 Suppl 1(Suppl 1):S5. PubMed ID: 17430572
[TBL] [Abstract][Full Text] [Related]
3. Are data from different gene expression microarray platforms comparable?
Järvinen AK; Hautaniemi S; Edgren H; Auvinen P; Saarela J; Kallioniemi OP; Monni O
Genomics; 2004 Jun; 83(6):1164-8. PubMed ID: 15177569
[TBL] [Abstract][Full Text] [Related]
4. Application and optimization of microarray technologies for human postmortem brain studies.
Ryan MM; Huffaker SJ; Webster MJ; Wayland M; Freeman T; Bahn S
Biol Psychiatry; 2004 Feb; 55(4):329-36. PubMed ID: 14960284
[TBL] [Abstract][Full Text] [Related]
5. Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays.
Wang Y; Barbacioru C; Hyland F; Xiao W; Hunkapiller KL; Blake J; Chan F; Gonzalez C; Zhang L; Samaha RR
BMC Genomics; 2006 Mar; 7():59. PubMed ID: 16551369
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of microarray data: a further analysis of microarray quality control (MAQC) data.
Chen JJ; Hsueh HM; Delongchamp RR; Lin CJ; Tsai CA
BMC Bioinformatics; 2007 Oct; 8():412. PubMed ID: 17961233
[TBL] [Abstract][Full Text] [Related]
7. Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms.
Barnes M; Freudenberg J; Thompson S; Aronow B; Pavlidis P
Nucleic Acids Res; 2005; 33(18):5914-23. PubMed ID: 16237126
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of DNA microarray results with quantitative gene expression platforms.
Canales RD; Luo Y; Willey JC; Austermiller B; Barbacioru CC; Boysen C; Hunkapiller K; Jensen RV; Knight CR; Lee KY; Ma Y; Maqsodi B; Papallo A; Peters EH; Poulter K; Ruppel PL; Samaha RR; Shi L; Yang W; Zhang L; Goodsaid FM
Nat Biotechnol; 2006 Sep; 24(9):1115-22. PubMed ID: 16964225
[TBL] [Abstract][Full Text] [Related]
9. Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements.
Carter SL; Eklund AC; Mecham BH; Kohane IS; Szallasi Z
BMC Bioinformatics; 2005 Apr; 6():107. PubMed ID: 15850491
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the latest commercial short and long oligonucleotide microarray technologies.
de Reyniès A; Geromin D; Cayuela JM; Petel F; Dessen P; Sigaux F; Rickman DS
BMC Genomics; 2006 Mar; 7():51. PubMed ID: 16539734
[TBL] [Abstract][Full Text] [Related]
11. Three microarray platforms: an analysis of their concordance in profiling gene expression.
Petersen D; Chandramouli GV; Geoghegan J; Hilburn J; Paarlberg J; Kim CH; Munroe D; Gangi L; Han J; Puri R; Staudt L; Weinstein J; Barrett JC; Green J; Kawasaki ES
BMC Genomics; 2005 May; 6():63. PubMed ID: 15876355
[TBL] [Abstract][Full Text] [Related]
12. Quality control for microarray analysis of human brain samples: The impact of postmortem factors, RNA characteristics, and histopathology.
Weis S; Llenos IC; Dulay JR; Elashoff M; Martínez-Murillo F; Miller CL
J Neurosci Methods; 2007 Sep; 165(2):198-209. PubMed ID: 17628689
[TBL] [Abstract][Full Text] [Related]
13. Expression Profiling Using Affymetrix GeneChip Microarrays.
Auer H; Newsom DL; Kornacker K
Methods Mol Biol; 2009; 509():35-46. PubMed ID: 19212713
[TBL] [Abstract][Full Text] [Related]
14. Microarray RNA transcriptional profiling: part I. Platforms, experimental design and standardization.
Ahmed FE
Expert Rev Mol Diagn; 2006 Jul; 6(4):535-50. PubMed ID: 16824028
[TBL] [Abstract][Full Text] [Related]
15. Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project.
Patterson TA; Lobenhofer EK; Fulmer-Smentek SB; Collins PJ; Chu TM; Bao W; Fang H; Kawasaki ES; Hager J; Tikhonova IR; Walker SJ; Zhang L; Hurban P; de Longueville F; Fuscoe JC; Tong W; Shi L; Wolfinger RD
Nat Biotechnol; 2006 Sep; 24(9):1140-50. PubMed ID: 16964228
[TBL] [Abstract][Full Text] [Related]
16. Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations.
Shippy R; Sendera TJ; Lockner R; Palaniappan C; Kaysser-Kranich T; Watts G; Alsobrook J
BMC Genomics; 2004 Sep; 5():61. PubMed ID: 15345031
[TBL] [Abstract][Full Text] [Related]
17. A comparison of cDNA, oligonucleotide, and Affymetrix GeneChip gene expression microarray platforms.
Woo Y; Affourtit J; Daigle S; Viale A; Johnson K; Naggert J; Churchill G
J Biomol Tech; 2004 Dec; 15(4):276-84. PubMed ID: 15585824
[TBL] [Abstract][Full Text] [Related]
18. DNA microarray analysis of postmortem brain tissue.
Mirnics K; Levitt P; Lewis DA
Int Rev Neurobiol; 2004; 60():153-81. PubMed ID: 15474590
[No Abstract] [Full Text] [Related]
19. Strategies for comparing gene expression profiles from different microarray platforms: application to a case-control experiment.
Severgnini M; Bicciato S; Mangano E; Scarlatti F; Mezzelani A; Mattioli M; Ghidoni R; Peano C; Bonnal R; Viti F; Milanesi L; De Bellis G; Battaglia C
Anal Biochem; 2006 Jun; 353(1):43-56. PubMed ID: 16624241
[TBL] [Abstract][Full Text] [Related]
20. Systematic order-dependent effect in expression values, variance, detection calls and differential expression in Affymetrix GeneChips.
Bjork KE; Kafadar K
Bioinformatics; 2007 Nov; 23(21):2873-80. PubMed ID: 17897972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
